A special report outlines the challenges — from unleashing the power of mRNA vaccines, to the battle for temporary intellectual-property relief. Within just a few months, pharmaceutical firms have produced hundreds of millions of doses of COVID-19 vaccine. But the world needs billions — and as fast as possible. Companies […]
Read More
Two-thirds of epidemiologists from leading academic institutions say the world will need new or modified vaccines for COVID-19 within a year, new research shows. In a survey of 77 epidemiologists from 28 countries by the People’s Vaccine Alliance, 66.2% predicted that the world has a year or less before variants […]
Read More
A new Ipsos-World Economic Forum survey shows a notable increase in COVID-19 vaccination intent since December in all 15 countries studied. Eighty-nine percent of people in Brazil say they’re ready to be vaccinated, with confidence also very high in Italy, China and Spain. Confidence in the vaccines has risen most […]
Read More
People with SARS-CoV-2, which is the virus that causes COVID-19, who show no symptoms may account for more than half of all transmission cases of the disease. A new study helps alleviate concerns that people who have been vaccinated may still be vulnerable to symptom-free, or “asymptomatic,” COVID-19 and will, […]
Read More
Créditos: Comité científico Covid
Read More
There’s no one “best” Covid-19 vaccine. To understand why you need to understand how vaccine efficacy is measured: Créditos: Comité científico Covid
Read More
As COVID-19 cases resulting from infection with SARS-CoV-2 variants accumulate in the US and around the world, one question looms large: How well do the COVID-19 vaccines developed so far protect against these novel coronavirus spinoffs? “The virus is telling us it’s going to throw out a lot of mutations,” […]
Read More